1by4 › Citations

Structural basis of RXR-DNA interactions.

Zhao Q, Chasse SA, Devarakonda S, Sierk ML, Ahvazi B, Rastinejad F
J Mol Biol 296 509-20 (2000)
Cited: 82 times
EuropePMC logo PMID: 10669605

Abstract

The 9-cis retinoic acid receptor, RXR, binds DNA effectively as a homodimer or as a heterodimer with other nuclear receptors. The DNA-binding sites for these RXR complexes are direct repeats of a consensus sequence separated by one to five base-pairs of intervening space. Here, we report the 2.1 A crystal structure of the RXR-DNA-binding domain as a homodimer in complex with its idealized direct repeat DNA target. The structure shows how a gene-regulatory site can induce conformational changes in a transcription factor that promote homo-cooperative assembly. Specifically, an alpha-helix in the T-box is disrupted to allow efficient DNA-binding and subunit dimerization. RXR displays a relaxed mode of sequence recognition, interacting with only three base-pairs in each hexameric half-site. The structure illustrates how site selection is achieved in this large eukaryotic transcription factor family through discrete protein-protein interactions and the use of tandem DNA binding sites with characteristic spacings.

Reviews - 1by4 mentioned but not cited (2)

  1. The retinoid X receptors and their ligands. Dawson MI, Xia Z. Biochim Biophys Acta 1821 21-56 (2012)
  2. Novel NR2F1 variants likely disrupt DNA binding: molecular modeling in two cases, review of published cases, genotype-phenotype correlation, and phenotypic expansion of the Bosch-Boonstra-Schaaf optic atrophy syndrome. Kaiwar C, Zimmermann MT, Ferber MJ, Niu Z, Urrutia RA, Klee EW, Babovic-Vuksanovic D. Cold Spring Harb Mol Case Stud 3 a002162 (2017)

Articles - 1by4 mentioned but not cited (18)

  1. Deamidation of human proteins. Robinson NE, Robinson AB. Proc Natl Acad Sci U S A 98 12409-12413 (2001)
  2. Identification of a binding motif specific to HNF4 by comparative analysis of multiple nuclear receptors. Fang B, Mane-Padros D, Bolotin E, Jiang T, Sladek FM. Nucleic Acids Res 40 5343-5356 (2012)
  3. A protein-DNA docking benchmark. van Dijk M, Bonvin AM. Nucleic Acids Res 36 e88 (2008)
  4. Energetics of the protein-DNA-water interaction. Spyrakis F, Cozzini P, Bertoli C, Marabotti A, Kellogg GE, Mozzarelli A. BMC Struct Biol 7 4 (2007)
  5. Pushing the limits of what is achievable in protein-DNA docking: benchmarking HADDOCK's performance. van Dijk M, Bonvin AM. Nucleic Acids Res 38 5634-5647 (2010)
  6. Pre- and post-docking sampling of conformational changes using ClustENM and HADDOCK for protein-protein and protein-DNA systems. Kurkcuoglu Z, Bonvin AMJJ. Proteins 88 292-306 (2020)
  7. A Structural Investigation into Oct4 Regulation by Orphan Nuclear Receptors, Germ Cell Nuclear Factor (GCNF), and Liver Receptor Homolog-1 (LRH-1). Weikum ER, Tuntland ML, Murphy MN, Ortlund EA. J Mol Biol 428 4981-4992 (2016)
  8. Benchmarks for flexible and rigid transcription factor-DNA docking. Kim R, Corona RI, Hong B, Guo JT. BMC Struct Biol 11 45 (2011)
  9. Control of gene expression by modulated self-assembly. Vilar JM, Saiz L. Nucleic Acids Res 39 6854-6863 (2011)
  10. High performance transcription factor-DNA docking with GPU computing. Wu J, Hong B, Takeda T, Guo JT. Proteome Sci 10 Suppl 1 S17 (2012)
  11. DNA-binding residues and binding mode prediction with binding-mechanism concerned models. Huang YF, Huang CC, Liu YC, Oyang YJ, Huang CK. BMC Genomics 10 Suppl 3 S23 (2009)
  12. Orphan nuclear receptor NGFI-B forms dimers with nonclassical interface. Calgaro MR, Neto Mde O, Figueira AC, Santos MA, Portugal RV, Guzzi CA, Saidemberg DM, Bleicher L, Vernal J, Fernandez P, Terenzi H, Palma MS, Polikarpov I. Protein Sci 16 1762-1772 (2007)
  13. Subtypes of associated protein-DNA (Transcription Factor-Transcription Factor Binding Site) patterns. Chan TM, Leung KS, Lee KH, Wong MH, Lau TC, Tsui SK. Nucleic Acids Res 40 9392-9403 (2012)
  14. The dipeptidyl peptidase IV inhibitors vildagliptin and K-579 inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. Chakraborty S, Rendón-Ramírez A, Ásgeirsson B, Dutta M, Ghosh AS, Oda M, Venkatramani R, Rao BJ, Dandekar AM, Goñi FM. F1000Res 2 286 (2013)
  15. A multidisciplinary approach disclosing unexplored Aflatoxin B1 roles in severe impairment of vitamin D mechanisms of action. Persico M, Sessa R, Cesaro E, Dini I, Costanzo P, Ritieni A, Fattorusso C, Grosso M. Cell Biol Toxicol 39 1275-1295 (2023)
  16. Integrative analysis reveals structural basis for transcription activation of Nurr1 and Nurr1-RXRα heterodimer. Zhao M, Wang N, Guo Y, Li J, Yin Y, Dong Y, Zhu J, Peng C, Xu T, Liu J. Proc Natl Acad Sci U S A 119 e2206737119 (2022)
  17. Searching for Low Probability Opening Events in a DNA Sliding Clamp. Esmaeeli R, Andal B, Perez A. Life (Basel) 12 261 (2022)
  18. Structural predictions of protein-DNA binding: MELD-DNA. Esmaeeli R, Bauzá A, Perez A. Nucleic Acids Res 51 1625-1636 (2023)


Reviews citing this publication (10)

  1. Overview of nomenclature of nuclear receptors. Germain P, Staels B, Dacquet C, Spedding M, Laudet V. Pharmacol Rev 58 685-704 (2006)
  2. Nuclear-receptor interactions on DNA-response elements. Khorasanizadeh S, Rastinejad F. Trends Biochem Sci 26 384-390 (2001)
  3. Understanding nuclear receptor form and function using structural biology. Rastinejad F, Huang P, Chandra V, Khorasanizadeh S. J Mol Endocrinol 51 T1-T21 (2013)
  4. Retinoic acid actions through mammalian nuclear receptors. Huang P, Chandra V, Rastinejad F. Chem Rev 114 233-254 (2014)
  5. General molecular biology and architecture of nuclear receptors. Pawlak M, Lefebvre P, Staels B. Curr Top Med Chem 12 486-504 (2012)
  6. Structural and functional analysis of domains of the progesterone receptor. Hill KK, Roemer SC, Churchill ME, Edwards DP. Mol Cell Endocrinol 348 418-429 (2012)
  7. Modulation of DNA-binding domains for sequence-specific DNA recognition. Marmorstein R, Fitzgerald MX. Gene 304 1-12 (2003)
  8. Overview of the structure-based non-genomic effects of the nuclear receptor RXRα. Chen L, Wu L, Zhu L, Zhao Y. Cell Mol Biol Lett 23 36 (2018)
  9. Dietary Phenolic Compounds Exert Some of Their Health-Promoting Bioactivities by Targeting Liver X Receptor (LXR) and Retinoid X Receptor (RXR). Domínguez-Avila JA. Foods 12 4205 (2023)
  10. The protein architecture and allosteric landscape of HNF4α. Rastinejad F. Front Endocrinol (Lausanne) 14 1219092 (2023)

Articles citing this publication (52)

  1. Structural basis of androgen receptor binding to selective androgen response elements. Shaffer PL, Jivan A, Dollins DE, Claessens F, Gewirth DT. Proc Natl Acad Sci U S A 101 4758-4763 (2004)
  2. Retinoic acid receptors: from molecular mechanisms to cancer therapy. di Masi A, Leboffe L, De Marinis E, Pagano F, Cicconi L, Rochette-Egly C, Lo-Coco F, Ascenzi P, Nervi C. Mol Aspects Med 41 1-115 (2015)
  3. Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor beta/delta. Shaw N, Elholm M, Noy N. J Biol Chem 278 41589-41592 (2003)
  4. Structure of the full human RXR/VDR nuclear receptor heterodimer complex with its DR3 target DNA. Orlov I, Rochel N, Moras D, Klaholz BP. EMBO J 31 291-300 (2012)
  5. SIRT1 deacetylates RORγt and enhances Th17 cell generation. Lim HW, Kang SG, Ryu JK, Schilling B, Fei M, Lee IS, Kehasse A, Shirakawa K, Yokoyama M, Schnölzer M, Kasler HG, Kwon HS, Gibson BW, Sato H, Akassoglou K, Xiao C, Littman DR, Ott M, Verdin E. J Exp Med 212 607-617 (2015)
  6. Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix. Gampe RT, Montana VG, Lambert MH, Wisely GB, Milburn MV, Xu HE. Genes Dev 14 2229-2241 (2000)
  7. Embryonic and fetal beta-globin gene repression by the orphan nuclear receptors, TR2 and TR4. Tanabe O, McPhee D, Kobayashi S, Shen Y, Brandt W, Jiang X, Campbell AD, Chen YT, Chang Cs, Yamamoto M, Tanimoto K, Engel JD. EMBO J 26 2295-2306 (2007)
  8. Imposex induction is mediated through the Retinoid X Receptor signalling pathway in the neogastropod Nucella lapillus. Castro LF, Lima D, Machado A, Melo C, Hiromori Y, Nishikawa J, Nakanishi T, Reis-Henriques MA, Santos MM. Aquat Toxicol 85 57-66 (2007)
  9. Structural basis of VDR-DNA interactions on direct repeat response elements. Shaffer PL, Gewirth DT. EMBO J 21 2242-2252 (2002)
  10. Monomeric complex of human orphan estrogen related receptor-2 with DNA: a pseudo-dimer interface mediates extended half-site recognition. Gearhart MD, Holmbeck SM, Evans RM, Dyson HJ, Wright PE. J Mol Biol 327 819-832 (2003)
  11. Nuclear import of the retinoid X receptor, the vitamin D receptor, and their mutual heterodimer. Yasmin R, Williams RM, Xu M, Noy N. J Biol Chem 280 40152-40160 (2005)
  12. Structure of the heterodimeric ecdysone receptor DNA-binding complex. Devarakonda S, Harp JM, Kim Y, Ozyhar A, Rastinejad F. EMBO J 22 5827-5840 (2003)
  13. Characterization of crab EcR and RXR homologs and expression during limb regeneration and oocyte maturation. Durica DS, Wu X, Anilkumar G, Hopkins PM, Chung AC. Mol Cell Endocrinol 189 59-76 (2002)
  14. Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements. Roemer SC, Donham DC, Sherman L, Pon VH, Edwards DP, Churchill ME. Mol Endocrinol 20 3042-3052 (2006)
  15. The C-terminal extension (CTE) of the nuclear hormone receptor DNA binding domain determines interactions and functional response to the HMGB-1/-2 co-regulatory proteins. Melvin VS, Roemer SC, Churchill ME, Edwards DP. J Biol Chem 277 25115-25124 (2002)
  16. Cross-Talk between PPARs and the Partners of RXR: A Molecular Perspective. Chan LS, Wells RA. PPAR Res 2009 925309 (2009)
  17. DNA complexed structure of the key transcription factor initiating development in sporulating bacteria. Zhao H, Msadek T, Zapf J, Madhusudan, Hoch JA, Varughese KI. Structure 10 1041-1050 (2002)
  18. The orphan COUP-TF nuclear receptors are markers for neurogenesis from cnidarians to vertebrates. Gauchat D, Escriva H, Miljkovic-Licina M, Chera S, Langlois MC, Begue A, Laudet V, Galliot B. Dev Biol 275 104-123 (2004)
  19. Structure and dynamics of a primordial catalytic fold generated by in vitro evolution. Chao FA, Morelli A, Haugner JC, Churchfield L, Hagmann LN, Shi L, Masterson LR, Sarangi R, Veglia G, Seelig B. Nat Chem Biol 9 81-83 (2013)
  20. Molecular basis of the interaction between IGFBP-3 and retinoid X receptor: role in modulation of RAR-signaling. Schedlich LJ, Graham LD, O'Han MK, Muthukaruppan A, Yan X, Firth SM, Baxter RC. Arch Biochem Biophys 465 359-369 (2007)
  21. Predicting specificity-determining residues in two large eukaryotic transcription factor families. Donald JE, Shakhnovich EI. Nucleic Acids Res 33 4455-4465 (2005)
  22. Creation and discovery of ligand-receptor pairs for transcriptional control with small molecules. Schwimmer LJ, Rohatgi P, Azizi B, Seley KL, Doyle DF. Proc Natl Acad Sci U S A 101 14707-14712 (2004)
  23. Crustacean retinoid-X receptor isoforms: distinctive DNA binding and receptor-receptor interaction with a cognate ecdysteroid receptor. Wu X, Hopkins PM, Palli SR, Durica DS. Mol Cell Endocrinol 218 21-38 (2004)
  24. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity. Solomon IH, Hager JM, Safi R, McDonnell DP, Redinbo MR, Ortlund EA. J Mol Biol 354 1091-1102 (2005)
  25. A progesterone receptor co-activator (JDP2) mediates activity through interaction with residues in the carboxyl-terminal extension of the DNA binding domain. Hill KK, Roemer SC, Jones DN, Churchill ME, Edwards DP. J Biol Chem 284 24415-24424 (2009)
  26. Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding. Roemer SC, Adelman J, Churchill ME, Edwards DP. Nucleic Acids Res 36 3655-3666 (2008)
  27. Structural basis of natural promoter recognition by a unique nuclear receptor, HNF4alpha. Diabetes gene product. Lu P, Rha GB, Melikishvili M, Wu G, Adkins BC, Fried MG, Chi YI. J Biol Chem 283 33685-33697 (2008)
  28. An intact DNA-binding domain is not required for peroxisome proliferator-activated receptor gamma (PPARgamma) binding and activation on some PPAR response elements. Temple KA, Cohen RN, Wondisford SR, Yu C, Deplewski D, Wondisford FE. J Biol Chem 280 3529-3540 (2005)
  29. Analysis of Usp DNA binding domain targeting reveals critical determinants of the ecdysone receptor complex interaction with the response element. Grad I, Niedziela-Majka A, Kochman M, Ozyhar A. Eur J Biochem 268 3751-3758 (2001)
  30. Directed evolution of ATP binding proteins from a zinc finger domain by using mRNA display. Cho GS, Szostak JW. Chem Biol 13 139-147 (2006)
  31. Cloning and characterization of retinoid X receptor (RXR) isoforms in the rock shell, Thais clavigera. Urushitani H, Katsu Y, Ohta Y, Shiraishi H, Iguchi T, Horiguchi T. Aquat Toxicol 103 101-111 (2011)
  32. Structure of a thyroid hormone receptor DNA-binding domain homodimer bound to an inverted palindrome DNA response element. Chen Y, Young MA. Mol Endocrinol 24 1650-1664 (2010)
  33. In-depth proteomic characterization of endogenous nuclear receptors in mouse liver. Liu Q, Ding C, Liu W, Song L, Liu M, Qi L, Fu T, Malovannaya A, Wang Y, Qin J, Zhen B. Mol Cell Proteomics 12 473-484 (2013)
  34. Dual FRET assay for detecting receptor protein interaction with DNA. Krusiński T, Ozyhar A, Dobryszycki P. Nucleic Acids Res 38 e108 (2010)
  35. The synthesis of tethered ligand dimers for PPARgamma-RXR protein heterodimers. Mohler DL, Shen G. Org Biomol Chem 4 2082-2087 (2006)
  36. RXRα Positively Regulates Expression of the Chicken PLIN1 Gene in a PPARγ-Independent Manner and Promotes Adipogenesis. Sun Y, Zhai G, Li R, Zhou W, Li Y, Cao Z, Wang N, Li H, Wang Y. Front Cell Dev Biol 8 349 (2020)
  37. Structural basis of natural promoter recognition by the retinoid X nuclear receptor. Osz J, McEwen AG, Poussin-Courmontagne P, Moutier E, Birck C, Davidson I, Moras D, Rochel N. Sci Rep 5 8216 (2015)
  38. Alternative splicing in the fiddler crab cognate ecdysteroid receptor: variation in receptor isoform expression and DNA binding properties in response to hormone. Durica DS, Das S, Najar F, Roe B, Phillips B, Kappalli S, Anilkumar G. Gen Comp Endocrinol 206 80-95 (2014)
  39. Detection of nucleic acid-nuclear hormone receptor complexes with mass spectrometry. Bich C, Bovet C, Rochel N, Peluso-Iltis C, Panagiotidis A, Nazabal A, Moras D, Zenobi R. J Am Soc Mass Spectrom 21 635-645 (2010)
  40. Gene-specific alterations of hepatic gene expression by ligand activation or hepatocyte-selective inhibition of retinoid X receptor-α signalling during inflammation. Kosters A, Tian F, Wan YJ, Karpen SJ. Liver Int 32 321-330 (2012)
  41. Probing biological activity through structural modelling of ligand-receptor interactions of 2,4-disubstituted thiazole retinoids. Haffez H, Chisholm DR, Tatum NJ, Valentine R, Redfern C, Pohl E, Whiting A, Przyborski S. Bioorg Med Chem 26 1560-1572 (2018)
  42. Stability of the Retinoid X Receptor-α Homodimer in the Presence and Absence of Rexinoid and Coactivator Peptide. Yang Z, Muccio DD, Melo N, Atigadda VR, Renfrow MB. Biochemistry 60 1165-1177 (2021)
  43. Cloning and functional characterization of a retinoid X receptor orthologue in Platynereis dumerilii: An evolutionary and toxicological perspective. André A, Ruivo R, Capitão A, Froufe E, Páscoa I, Costa Castro LF, Santos MM. Chemosphere 182 753-761 (2017)
  44. Molecular characterization of RXR (Retinoid X Receptor) gene isoforms from the bivalve species Chlamys farreri. Lv J, Feng L, Bao Z, Guo H, Zhang Y, Jiao W, Zhang L, Wang S, He Y, Hu X. PLoS One 8 e74290 (2013)
  45. Overlapping but separable determinants of DNA binding and nuclear localization map to the C-terminal end of the Caenorhabditis elegans DAF-12 DNA binding domain. Shostak Y, Yamamoto KR. J Biol Chem 280 6554-6560 (2005)
  46. Cloning, mRNA expression and transcriptional regulation of five retinoid X receptor subtypes in yellow catfish Pelteobagrus fulvidraco by insulin. Pan YX, Luo Z, Wu K, Zhang LH, Xu YH, Chen QL. Gen Comp Endocrinol 225 133-141 (2016)
  47. Equilibrium analysis of the DNA binding domain of the ultraspiracle protein interaction with the response element from the hsp27 gene promoter--the application of molecular beacon technology. Krusiński T, Wietrzych M, Grad I, Ozyhar A, Dobryszycki P. J Fluoresc 18 1-10 (2008)
  48. Structural overview and perspectives of the nuclear receptors, a major family as the direct targets for small-molecule drugs. Li F, Song C, Zhang Y, Wu D. Acta Biochim Biophys Sin (Shanghai) 54 12-24 (2022)
  49. Kinetic characterization of the retinoic X receptor binding to specific and unspecific DNA oligoduplexes with a quartz crystal microbalance. Rodrigues RM, de-Carvalho J, Ferreira GN. Analyst 139 3434-3440 (2014)
  50. Next-generation retinoid X receptor agonists increase ATRA signaling in organotypic epithelium cultures and have distinct effects on receptor dynamics. Melo N, Belyaeva OV, Berger WK, Halasz L, Yu J, Pilli N, Yang Z, Klyuyeva AV, Elmets CA, Atigadda V, Muccio DD, Kane MA, Nagy L, Kedishvili NY, Renfrow MB. J Biol Chem 299 102746 (2023)
  51. Nuclear receptor RXRα binds the precursor of miR-103 to inhibit its maturation. Ye X, Yang Y, Yao J, Wang M, Liu Y, Xie G, Zeng Z, Zhang XK, Zhou H. BMC Biol 21 197 (2023)
  52. Structural basis of the farnesoid X receptor/retinoid X receptor heterodimer on inverted repeat DNA. Jiang L, Liu X, Liang X, Dai S, Wei H, Guo M, Chen Z, Xiao D, Chen Y. Comput Struct Biotechnol J 21 3149-3157 (2023)


Quick links